PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 7:28 AM ET

Sponsor Check › Person

RW
No photo found yet (own website and image search run after this page is viewed)

Robert S. Whitehead

Named as an officer, director or promoter on SEC Form D filings · NC, FL · Aug 18, 2009 → Jun 8, 2015

7deals (issuers)
$94.9Mreported sold
384investors
28Form D filings
2009–2015years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:19 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Robert S. Whitehead is listed as an executive officer and director on 28 SEC Form D filings by 7 issuers between Aug 2009 and Aug 2025. Largest by amount reported sold: Sprout Pharmaceuticals, Inc. (Raleigh, NC — pharmaceuticals — 2012–2015; $50M reported sold to 88 investors), Sprout2 Inc. (Raleigh, NC — pharmaceuticals — 2018–2024; $28M reported sold to 203 investors), Continuity Biosciences, LLC (Bradenton, FL — biotechnology — 2024–2025; $8.42M reported sold to 13 investors), Slate Pharmaceuticals, Inc. (Durham, NC — pharmaceuticals — 2009–2010; $2.79M reported sold to 40 investors), Helloo Yelloo, LLC (Tierra Verde, FL — industry reported as "Other" — 2018; $2.32M reported sold to 17 investors) and 2 more (all listed below).

What this means A repeat sponsor — 7 separate companies raised money with this person listed as executive officer and director, over about 16 years. Across those companies the filings report $94.9M sold in total.

Listed alongside W. Robert Dahl (13 shared filings), Matthew Petzold (12 shared filings), Anthony Wild (11 shared filings), Douglas Eckert (11 shared filings), Michael Ford (11 shared filings) and 24 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Robert. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 8 bankruptcy cases matching the name listed in Key records below.

What this means 8 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 28 public filings for Robert S. Whitehead and found 17 differences, 1 worth asking the sponsor about: Form D filed 424 days after the first sale; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Robert S. Whitehead has not run yet — it is #4,653 of 22,409 in line; searches run around the clock at the hosts' allowed rate. Searched so far: 628 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:19 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: VA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Robert S. Whitehead..

State securities regulators: Securities regulators searched (3,318 actions): AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE DOJ Investor Protection Unit (257 actions, 1987–2026), TX State Securities Board (586 actions, 2006–2026), WA DFI (2,039 actions, 2001–2026) — last crawled Oct 23, 2026, 9:57 PM ET. No machine-readable public listing today for CO, FL, IA, IN, MN, NE, NJ, NY, OH, UT, VA (see docs/state-regulators.md).

3. Bankruptcies

8 cases: 8 closed (disposition not in docket feed)

Robert C. Whitehead, Sr. closed
United States Bankruptcy Court, E.D. North Carolina · No. 14-02485 · Filed May 1, 2014 · Closed Jun 22, 2015
Role of Robert C. Whitehead, Sr.: Debtor · Outcome: Case closed 2015-06-22 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 142 federal dockets); 5 people with this name in Form D filings; court in the person's filing state (NC); middle initial differs
Robert C. Whitehead, Sr. closed
United States Bankruptcy Court, E.D. North Carolina · No. 13-05730 · Filed Sep 11, 2013 · Closed Apr 22, 2014
Role of Robert C. Whitehead, Sr.: Debtor · Outcome: Case closed 2014-04-22 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 142 federal dockets); 5 people with this name in Form D filings; court in the person's filing state (NC); middle initial differs
Robert Whitehead and Elayne Whitehead closed
United States Bankruptcy Court, M.D. Florida · No. 2:09-bk-04748 · Filed Mar 16, 2009 · Closed Oct 23, 2014
Role of Robert Whitehead and Elayne Whitehead: Debtor · Outcome: Case closed 2014-10-23 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 142 federal dockets); 5 people with this name in Form D filings; court in the person's filing state (FL); middle initial differs
ROBERT E. WHITEHEAD and OPAL M. WHITEHEAD closed
United States Bankruptcy Court, N.D. Florida · No. 03-20773 · Filed Aug 29, 2003 · Closed Jan 12, 2004
Role of ROBERT E. WHITEHEAD and OPAL M. WHITEHEAD: Debtor · Outcome: Case closed 2004-01-12 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 142 federal dockets); 5 people with this name in Form D filings; court in the person's filing state (FL); middle initial differs
ROBERT A. WHITEHEAD and CHARLOTTE D. WHITEHEAD closed
United States Bankruptcy Court, N.D. Florida · No. 01-70419 · Filed May 7, 2001 · Closed Aug 28, 2001
Role of ROBERT A. WHITEHEAD and CHARLOTTE D. WHITEHEAD: Debtor · Outcome: Case closed 2001-08-28 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 142 federal dockets); 5 people with this name in Form D filings; court in the person's filing state (FL); middle initial differs
Robert Whitehead closed
United States Bankruptcy Court, E.D. North Carolina · No. 01-02784 · Filed Apr 10, 2001 · Closed Aug 12, 2001
Role of Robert Whitehead: Debtor · Outcome: Case closed 2001-08-12 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 142 federal dockets); 5 people with this name in Form D filings; court in the person's filing state (NC)
Robert J Whitehead closed
United States Bankruptcy Court, E.D. North Carolina · No. 97-06909 · Filed Dec 4, 1997 · Closed Apr 26, 1999
Role of Robert J Whitehead: Debtor · Outcome: Case closed 1999-04-26 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 142 federal dockets); 5 people with this name in Form D filings; court in the person's filing state (NC); middle initial differs
Robert H. Whitehead closed
United States Bankruptcy Court, S.D. Florida. · No. 95-15583 · Filed Nov 14, 1995 · Closed Aug 6, 2001
Role of Robert H. Whitehead: Debtor · Outcome: Case closed 2001-08-06 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 142 federal dockets); 5 people with this name in Form D filings; court in the person's filing state (FL); middle initial differs
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:19 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

17 differences found between the filings for Robert S. Whitehead — 1 worth asking about (compared 28 filings on Oct 24, 2026)

Note · Sep 27, 2010

15% of the money raised went to insiders — Slate Pharmaceuticals, Inc.

The Sep 27, 2010 Form D reports $1,990,000 sold and $300,000 of the proceeds used for payments to officers, directors or promoters (marked as an estimate). Issuer's note: "The $300,000 represents proceeds that may be applied to the salary of Robert S. Whitehead, President of Slate Pharmaceuticals, Inc., as part of the use of proceeds for working capital.".

What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.

Form D · Sep 27, 2010 ↗Slate Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Aug 18, 2009

14% of the money raised went to insiders — Slate Pharmaceuticals, Inc.

The Aug 18, 2009 Form D reports $970,630 sold and $140,000 of the proceeds used for payments to officers, directors or promoters (marked as an estimate). Issuer's note: "The $140,000 represents proceeds that may be applied to the salary of Robert S. Whitehead, President of Slate Pharmaceuticals, Inc., as part of the use of proceeds for working capital.".

What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.

Form D · Aug 18, 2009 ↗Slate Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Worth asking · Oct 21, 2019 – Dec 18, 2020

Form D filed 424 days after the first sale — Studfinder, LLC

The filing says the first sale was Oct 21, 2019. The Form D was filed Dec 18, 2020 — 424 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 409 days past that.

What this means The notice went in months after money was taken in. Late notices are common and carry no penalty by themselves, but it is fair to ask the sponsor why the paperwork lagged.

Form D · Dec 18, 2020 ↗Studfinder, LLC — PartnerFacts page ↗
Sources
Note · Jul 13, 2017 – Jul 31, 2017

Form D filed 18 days after the first sale — Liquid Gold, LLC

The filing says the first sale was Jul 13, 2017. The Form D was filed Jul 31, 2017 — 18 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 3 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Jul 31, 2017 ↗Liquid Gold, LLC — PartnerFacts page ↗
Sources
Note · May 22, 2015 – Jun 8, 2015

Form D filed 17 days after the first sale — Sprout Pharmaceuticals, Inc.

The filing says the first sale was May 22, 2015. The Form D was filed Jun 8, 2015 — 17 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 2 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Jun 8, 2015 ↗Sprout Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Sep 13, 2010 – Aug 19, 2025

10 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Continuity Biosciences, LLC (latest filing Aug 19, 2025) · No amendment in the last 12 months on an offering that may still be open — Sprout2 Inc. (latest filing Dec 23, 2024) · No amendment in the last 12 months on an offering that may still be open — Continuity Biosciences, LLC (latest filing Jul 2, 2024) · No amendment in the last 12 months on an offering that may still be open — Sprout2 Inc. (latest filing Apr 14, 2023) · No amendment in the last 12 months on an offering that may still be open — Sprout2 Inc. (latest filing Aug 15, 2022) · and 5 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Aug 19, 2025 ↗Continuity Biosciences, LLC — PartnerFacts page ↗Form D · Dec 23, 2024 ↗Sprout2 Inc. — PartnerFacts page ↗
Sources
Note · Jul 2, 2024 – Jun 4, 2025

Robert S. Whitehead's role changed at Continuity Biosciences, LLC: executive officer, director → director

The Jul 2, 2024 filing lists Robert S. Whitehead as executive officer, director; the Jun 4, 2025 Form D lists director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Jul 2, 2024 ↗Form D · Jun 4, 2025 ↗Robert S. Whitehead — PartnerFacts page ↗Continuity Biosciences, LLC — PartnerFacts page ↗
Sources
Note · Jan 4, 2018 – Aug 16, 2019

Robert S. Whitehead's role changed at Sprout2 Inc.: executive officer, director → director

The Jan 4, 2018 filing lists Robert S. Whitehead as executive officer, director; the Aug 16, 2019 Form D lists director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Jan 4, 2018 ↗Form D · Aug 16, 2019 ↗Robert S. Whitehead — PartnerFacts page ↗Sprout2 Inc. — PartnerFacts page ↗
Sources
Note · May 6, 2022 – Aug 15, 2022

Offering amount changed between filings — Sprout2 Inc.

The May 6, 2022 filing says $27,000,000 offered; the Aug 15, 2022 Form D/A says $30,000,000.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D/A (earlier) · May 6, 2022 ↗Form D/A (later) · Aug 15, 2022 ↗Sprout2 Inc. — PartnerFacts page ↗
Sources
Note · Sep 15, 2021 – May 6, 2022

Offering amount changed between filings — Sprout2 Inc.

The Sep 15, 2021 filing says $18,700,000 offered; the May 6, 2022 Form D/A says $27,000,000.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D/A (earlier) · Sep 15, 2021 ↗Form D/A (later) · May 6, 2022 ↗Sprout2 Inc. — PartnerFacts page ↗
Sources
Note · Dec 10, 2020 – Sep 15, 2021

Offering amount changed between filings — Sprout2 Inc.

The Dec 10, 2020 filing says $10,000,000 offered; the Sep 15, 2021 Form D/A says $18,700,000.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · Dec 10, 2020 ↗Form D/A (later) · Sep 15, 2021 ↗Sprout2 Inc. — PartnerFacts page ↗
Sources
Note · Aug 18, 2009 – Jul 31, 2017

Robert S. Whitehead is written 3 different ways on the filings

listed as "Robert Stanley Whitehead" on 4 filings (from Aug 18, 2009), and "Robert S. Whitehead" on 7 filings (from Mar 21, 2012), and "Robert Whitehead" on 17 filings (from Jul 31, 2017).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Aug 18, 2009 ↗Form D · Mar 21, 2012 ↗Form D · Jul 31, 2017 ↗Robert S. Whitehead — PartnerFacts page ↗
Sources
Note · Aug 18, 2009 – Sep 27, 2010

Reported revenue range changed between filings — Slate Pharmaceuticals, Inc.

"Not Applicable" (Aug 18, 2009); then "Decline to Disclose" (Sep 27, 2010).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Aug 18, 2009 ↗Form D · Sep 27, 2010 ↗Slate Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Dec 28, 2010

Same name, different state: "Robert Whitehead" (MI) is a separate record

This page covers filings where the address state is NC or FL. A separate record, "Robert Whitehead" with address state MI, is listed on 1 filing — most recently by MEDITRINA PHARMACEITICALS INC (Dec 28, 2010). Both records have filings in the same period (Dec 28, 2010).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Robert Whitehead (MI) — PartnerFacts page ↗Form D · Dec 28, 2010 ↗MEDITRINA PHARMACEITICALS INC — PartnerFacts page ↗Robert S. Whitehead (NC,FL) — this page ↗
Sources
Note · Jan 4, 2018 – Aug 16, 2019

Address moved from Wayne, PA to Raleigh, NC — Sprout2 Inc.

The people listed on the Jan 4, 2018 filing give Wayne, PA; on the Aug 16, 2019 filing they give Raleigh, NC.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Jan 4, 2018 ↗Form D · Aug 16, 2019 ↗Sprout2 Inc. — PartnerFacts page ↗
Sources
Note · Nov 30, 2017 – Feb 8, 2019

Address moved from Sarasota, FL to Tierra Verde, FL — Studfinder, LLC

The people listed on the Nov 30, 2017 filing give Sarasota, FL; on the Feb 8, 2019 filing they give Tierra Verde, FL.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Nov 30, 2017 ↗Form D · Feb 8, 2019 ↗Studfinder, LLC — PartnerFacts page ↗
Sources
Note · Aug 18, 2009 – Aug 19, 2025

Robert S. Whitehead is listed with 2 different address states: NC, FL

NC on 18 filings (Aug 18, 2009 to Dec 23, 2024); FL on 10 filings (Jul 31, 2017 to Aug 19, 2025).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · Aug 18, 2009 ↗Form D · Jul 31, 2017 ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

0 of 21 offerings report sales commissions; 0 report finder's fees; 4 report proceeds to related persons totalling $2,590,000. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Aug 19, 2025 D
Continuity Biosciences, LLC
File 021-555132
$0$0$0None listed on this filingEDGAR ↗
Jun 4, 2025 D
Continuity Biosciences, LLC
File 021-548002
$0$0$0None listed on this filingEDGAR ↗
Dec 23, 2024 D
Sprout2 Inc.
File 021-533125
$0$0$0None listed on this filingEDGAR ↗
Jul 2, 2024 D
Continuity Biosciences, LLC
File 021-517688
$0$0$0None listed on this filingEDGAR ↗
Apr 14, 2023 D
Sprout2 Inc.
File 021-478864
$0$0$550,000 (est.)
A portion of the proceeds may be used for normal payroll and benefits costs of officers who are also employees of the Issuer.
None listed on this filingEDGAR ↗
Aug 15, 2022 D/A
Sprout2 Inc.
File 021-382871
$0$0$1,600,000 (est.)
A portion of the proceeds may be used for normal payroll and benefits costs of officers who are also employees of the Issuer.
None listed on this filingEDGAR ↗
Jan 11, 2021 D
Studfinder, LLC
File 021-385812
$0$0$0None listed on this filingEDGAR ↗
Dec 18, 2020 D
Studfinder, LLC
File 021-383735
$0$0$0None listed on this filingEDGAR ↗
Aug 16, 2019 D
Sprout2 Inc.
File 021-346722
$0$0$0None listed on this filingEDGAR ↗
Feb 8, 2019 D
Studfinder, LLC
File 021-332444
$0$0$0None listed on this filingEDGAR ↗
Nov 14, 2018 D
Helloo Yelloo, LLC
File 021-325738
$0$0$0None listed on this filingEDGAR ↗
Jan 4, 2018 D
Sprout2 Inc.
File 021-302368
$0$0$0None listed on this filingEDGAR ↗
Nov 30, 2017 D
Studfinder, LLC
File 021-299774
$0$0$0None listed on this filingEDGAR ↗
Jul 31, 2017 D
Liquid Gold, LLC
File 021-291765
$0$0$0None listed on this filingEDGAR ↗
Jun 8, 2015 D
Sprout Pharmaceuticals, Inc.
File 021-241312
$0$0$0
The proceeds from the offering will be used for working capital purposes, of which a portion may be used to pay the salaries of the Company's executive officers.
N/A no CRD number reportedEDGAR ↗
Jul 11, 2014 D
Sprout Pharmaceuticals, Inc.
File 021-220803
$0$0$0
The proceeds from the offering will be used for working capital purposes, of which a portion may be used to pay the salaries of the Company's executive officers.
N/A no CRD number reportedEDGAR ↗
Jul 26, 2013 D/A
Sprout Pharmaceuticals, Inc.
File 021-198572
$0$0$0
The proceeds from the offering will be used for working capital purposes, of which a portion may be used to pay the salaries of the Issuer's executive officers.
N/A no CRD number reportedEDGAR ↗
Jul 11, 2012 D/A
Sprout Pharmaceuticals, Inc.
File 021-180560
$0$0$0
The proceeds from the offering will be used for working capital purposes, of which a portion may be used to pay the salaries of the Issuer's executive officers.
N/A no CRD number reportedEDGAR ↗
Mar 21, 2012 D
Sprout Pharmaceuticals, Inc.
File 021-175342
$0$0$0
The Proceeds will be used for working capital purposes, of which a portion will be used to pay the salaries of the Issuer's executive officers.
N/A no CRD number reportedEDGAR ↗
Sep 27, 2010 D
Slate Pharmaceuticals, Inc.
File 021-148195
$0$0$300,000 (est.)
The $300,000 represents proceeds that may be applied to the salary of Robert S. Whitehead, President of Slate Pharmaceuticals, Inc., as part of the use of proceeds for working capital.
N/A no CRD number reportedEDGAR ↗
Jan 29, 2010 D/A
Slate Pharmaceuticals, Inc.
File 021-133739
$0$0$140,000 (est.)
The $140,000 represents proceeds that may be applied to the salary of Robert S. Whitehead, President of Slate Pharmaceuticals, Inc., as part of the use of proceeds for working capital.
N/A no CRD number reportedEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 7

Every issuer that named Robert S. Whitehead on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

CB
Biotechnology

Continuity Biosciences, LLC

Bradenton, FL · Jul 2, 2024 → Aug 19, 2025 · 3 filings
  • Aug 19, 2025 · D · $8,424,490 sold of $12,000,000 · 13 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 4, 2025 · D · $1,000,000 sold of $1,000,000 · 13 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 2, 2024 · D · $2,450,000 sold of $5,000,000 · 10 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $8.42M from 13 investors (70% of the $12M target) as of the latest filing. Robert is listed as director, executive officer on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

S
Pharmaceuticals

Sprout2 Inc.

Raleigh, NC · Jan 4, 2018 → Dec 23, 2024 · 8 filings
  • Dec 23, 2024 · D · $10,557,600 sold of $12,000,000 · 51 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 14, 2023 · D · $7,064,364 sold of $10,000,000 · 43 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 15, 2022 · D/A · $27,969,129 sold of $30,000,000 · 91 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 6, 2022 · D/A · $25,069,129 sold of $27,000,000 · 85 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 15, 2021 · D/A · $12,396,129 sold of $18,700,000 · 64 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 10, 2020 · D · $8,126,129 sold of $10,000,000 · 59 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 16, 2019 · D · $15,900,000 sold of $20,000,000 · 110 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 4, 2018 · D · $4,500,000 sold of $6,600,000 · 203 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $28M from 203 investors (100% of the $12M target) as of the latest filing. Robert is listed as director, executive officer on 8 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

S
Other

Studfinder, LLC

Tierra Verde, FL · Nov 30, 2017 → Jan 11, 2021 · 4 filings
  • Jan 11, 2021 · D · $920,000 sold of $920,000 · 14 investors · min. No minimum reported · role: Executive Officer (Manager of RSW Consultants, LLC, the Manager) EDGAR ↗
  • Dec 18, 2020 · D · $1,508,000 sold of $1,508,000 · 14 investors · min. No minimum reported · role: Executive Officer (Manager of RSW Consultants, LLC, the Manager) EDGAR ↗
  • Feb 8, 2019 · D · $1,160,000 sold of $1,160,000 · 11 investors · min. No minimum reported · role: Executive Officer (Manager of the Manager) EDGAR ↗
  • Nov 30, 2017 · D · $1,035,000 sold of $1,035,000 · 13 investors · min. No minimum reported · role: Executive Officer (Manager) EDGAR ↗

Raised $1.51M from 14 investors (100% of the $920K target) as of the latest filing. Robert is listed as executive officer on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

HY
Other

Helloo Yelloo, LLC

Tierra Verde, FL · Nov 14, 2018
  • Nov 14, 2018 · D · $2,323,000 sold of $2,323,000 · 17 investors · min. No minimum reported · role: Executive Officer (Manager of the Manager) EDGAR ↗

Raised $2.32M from 17 investors (100% of the $2.32M target) as of the latest filing. Robert is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

LG
Other

Liquid Gold, LLC

Sarasota, FL · Jul 31, 2017
  • Jul 31, 2017 · D · $1,900,000 sold of $1,900,000 · 9 investors · min. No minimum reported · role: Executive Officer (Manager) EDGAR ↗

Raised $1.9M from 9 investors (100% of the $1.9M target) as of the latest filing. Robert is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

SP
Pharmaceuticals

Sprout Pharmaceuticals, Inc.

Raleigh, NC · Mar 21, 2012 → Jun 8, 2015 · 7 filings
  • Jun 8, 2015 · D · $50,000,008 sold of $50,000,008 · 5 investors · min. No minimum reported · role: Executive Officer, Director (Director, Executive Director) EDGAR ↗
  • Jul 11, 2014 · D · $4,303,856 sold of $15,000,000 · 69 investors · min. $50,000 · role: Executive Officer, Director (Director, Chief Executive Officer) EDGAR ↗
  • Jul 26, 2013 · D/A · $9,999,997 sold of $10,000,000 · 88 investors · min. $50,000 · role: Executive Officer, Director (Director, President and Chief Executive Officer) EDGAR ↗
  • Jun 25, 2013 · D · $4,791,913 sold of $10,000,000 · 63 investors · min. $50,000 · role: Executive Officer, Director (Director, President and Chief Executive Officer) EDGAR ↗
  • Jul 11, 2012 · D/A · $20,000,000 sold of $20,000,000 · 59 investors · min. $50,000 · role: Executive Officer, Director (Director, President and Chief Executive Officer) EDGAR ↗
  • Jun 29, 2012 · D · $17,554,341 sold of $20,000,000 · 55 investors · min. $50,000 · role: Executive Officer, Director (Director, President and Chief Executive Officer) EDGAR ↗
  • Mar 21, 2012 · D · $5,000,000 sold of $5,000,000 · 61 investors · min. $50,000 · role: Executive Officer, Director (Director, President and Chief Executive Officer) EDGAR ↗

Raised $50M from 88 investors (100% of the $50M target) as of the latest filing. Robert is listed as executive officer, director on 7 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

SP
Pharmaceuticals

Slate Pharmaceuticals, Inc.

Durham, NC · Aug 18, 2009 → Sep 27, 2010 · 4 filings
  • Sep 27, 2010 · D · $1,990,000 sold of $2,000,000 · 40 investors · min. $1 · role: Executive Officer, Director EDGAR ↗
  • Jan 29, 2010 · D/A · $2,787,000 sold of $2,787,000 · 33 investors · min. $1 · role: Executive Officer, Director EDGAR ↗
  • Nov 19, 2009 · D/A · $2,616,950 sold of $2,787,000 · 33 investors · min. $1 · role: Executive Officer, Director EDGAR ↗
  • Aug 18, 2009 · D · $970,630 sold of $2,787,000 · 13 investors · min. $1 · role: Executive Officer, Director EDGAR ↗

Raised $2.79M from 40 investors (100% of the $2M target) as of the latest filing. Robert is listed as executive officer, director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Other pages with the same name (4)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

People around Robert 29

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

WD
No photo found yet (own website and image search run after this page is viewed)
Person

W. Robert Dahl

Director · 13 shared filings (2 issuers)

Listed on the same filings as Robert S. Whitehead. Their page shows their other deals.

MP
No photo found yet (own website and image search run after this page is viewed)
Person

Matthew Petzold

Executive Officer · 12 shared filings (2 issuers)

Listed on the same filings as Robert S. Whitehead. Their page shows their other deals.

MF
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Ford

Director · 11 shared filings (2 issuers)

Listed on the same filings as Robert S. Whitehead. Their page shows their other deals.

RD
No photo found yet (own website and image search run after this page is viewed)
Person

Richard DeSchutter

Director · 11 shared filings (2 issuers)

Listed on the same filings as Robert S. Whitehead. Their page shows their other deals.

TM
No photo found yet (own website and image search run after this page is viewed)
Person

Trygve Mikkelsen

Director · 11 shared filings (2 issuers)

Listed on the same filings as Robert S. Whitehead. Their page shows their other deals.

AW
No photo found yet (own website and image search run after this page is viewed)
Person

Anthony Wild

Director · 11 shared filings (2 issuers)

Listed on the same filings as Robert S. Whitehead. Their page shows their other deals.

DE
No photo found yet (own website and image search run after this page is viewed)
Person

Douglas Eckert

Director, Executive Officer · 11 shared filings (2 issuers)

Listed on the same filings as Robert S. Whitehead. Their page shows their other deals.

CW
No photo found yet (own website and image search run after this page is viewed)
Person

Cynthia Whitehead

Executive Officer, Director · 8 shared filings (2 issuers)

Listed on the same filings as Robert S. Whitehead. Their page shows their other deals.

BG
No photo found yet (own website and image search run after this page is viewed)
Person

Braxton Goodrich

Director · 7 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Robert S. Whitehead. Their page shows their other deals.

CE
No photo found yet (own website and image search run after this page is viewed)
Person

Cynthia Eckert

Executive Officer, Director · 7 shared filings (1 issuer)

Listed on the same filings as Robert S. Whitehead. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

James Symons

Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as Robert S. Whitehead. Their page shows their other deals.

FP
No photo found yet (own website and image search run after this page is viewed)
Person

Fred Pruden

Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as Robert S. Whitehead. Their page shows their other deals.

WD
No photo found yet (own website and image search run after this page is viewed)
Person

William Robert Dahl

Director · 4 shared filings (1 issuer)

Listed on the same filings as Robert S. Whitehead. Their page shows their other deals.

AO
No photo found yet (own website and image search run after this page is viewed)
Person

Adele C. Oliva

Director · 3 shared filings (1 issuer) · also on 19 other issuers

Adele C. Oliva is on 20 issuers in total — a repeat sponsor. Their page lists every one.

GB
No photo found yet (own website and image search run after this page is viewed)
Person

Gail Becker

Director · 3 shared filings (1 issuer)

Listed on the same filings as Robert S. Whitehead. Their page shows their other deals.

SM
No photo found yet (own website and image search run after this page is viewed)
Person

Sandra McGlothlin

Director · 3 shared filings (1 issuer)

Listed on the same filings as Robert S. Whitehead. Their page shows their other deals.

KC
No photo found yet (own website and image search run after this page is viewed)
Person

Kenneth Ramsey Couch

Director · 2 shared filings (1 issuer)

Listed on the same filings as Robert S. Whitehead. Their page shows their other deals.

AT
No photo found yet (own website and image search run after this page is viewed)
Person

Anne Tomalin

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Robert S. Whitehead. Their page shows their other deals.

JP
No photo found yet (own website and image search run after this page is viewed)
Person

James Pruden

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Robert S. Whitehead. Their page shows their other deals.

JT
No photo found yet (own website and image search run after this page is viewed)
Person

Josephine Torrente

Executive Officer, Director · 2 shared filings (2 issuers)

Listed on the same filings as Robert S. Whitehead. Their page shows their other deals.

RD
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Dahl

Director · 2 shared filings (2 issuers) · also on 2 other issuers

Listed on the same filings as Robert S. Whitehead. Their page shows their other deals.

EA
No photo found yet (own website and image search run after this page is viewed)
Person

Eric Atkins

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Robert S. Whitehead. Their page shows their other deals.

AW
No photo found yet (own website and image search run after this page is viewed)
Person

Allen R. Weiss

Director · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Robert S. Whitehead. Their page shows their other deals.

RV
No photo found yet (own website and image search run after this page is viewed)
Person

Ramakrishna Venugopalan

Executive Officer, Director · 2 shared filings (1 issuer)

Listed on the same filings as Robert S. Whitehead. Their page shows their other deals.

MF
No photo found yet (own website and image search run after this page is viewed)
Person

Michael L. Fowler

Director · 2 shared filings (1 issuer)

Listed on the same filings as Robert S. Whitehead. Their page shows their other deals.

MR
No photo found yet (own website and image search run after this page is viewed)
Person

Monica P. Reed

Director · 2 shared filings (1 issuer)

Listed on the same filings as Robert S. Whitehead. Their page shows their other deals.

RF
No photo found yet (own website and image search run after this page is viewed)
Person

Rich Franco

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Robert S. Whitehead. Their page shows their other deals.

MH
No photo found yet (own website and image search run after this page is viewed)
Person

Margaret Henry

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Robert S. Whitehead. Their page shows their other deals.

JD
No photo found yet (own website and image search run after this page is viewed)
Person

Joseph DeSimone

Director · 1 shared filing (1 issuer)

Listed on the same filings as Robert S. Whitehead. Their page shows their other deals.

The team behind the deals

Same business address

51 other issuers file from the same address (first 50 shown)

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 7 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Robert S. Whitehead by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 7 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Robert S. Whitehead is listed on: none on file. No website or social profile named in Sprout Pharmaceuticals, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #301,819 of 374,652 in line (1,111 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Raleigh, NC). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗North Carolina eCourts portal ↗Hillsborough County FL Clerk (HOVER) ↗Miami-Dade Clerk online case search ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

North Carolina Secretary of State business search ↗Florida Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Robert S. Whitehead appears on a new Form D, or when a court case or SEC action is matched to them. See plans →